Edward J. Richards
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Melanoma and MAPK Pathways, Lung Cancer Treatments and Mutations, Cancer-related molecular mechanisms research, RNA modifications and cancer
Most-Cited Works
- → Long Non-coding RNAs (LncRNA) Regulated by Transforming Growth Factor (TGF) β(2015)146 cited
- → Human induced pluripotent stem cell-derived glial cells and neural progenitors display divergent responses to Zika and dengue infections(2018)142 cited
- → A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer(2015)111 cited
- → Evaluation of Tyro3 Expression, Gas6-Mediated Akt Phosphorylation, and the Impact of Anti-Tyro3 Antibodies in Melanoma Cell Lines(2013)47 cited
- → JNK Pathway Activation Modulates Acquired Resistance to EGFR/HER2–Targeted Therapies(2016)23 cited
- → Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer(2022)16 cited
- → Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β. LncRNA-HIT-MEDIATED TGF-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY EPITHELIA.(2016)7 cited
- → Abstract 1904: MiR641 regulates EMT, ovarian cancer stem cell and angiogenesis by targeting p63/miR200 axis(2016)2 cited
- → Abstract B28: MicroRNA-641 activates MAPK by targeting NF1 and cooperates with its host gene AKT2 in human cancer(2012)2 cited
- → Abstract 998: LncRNA WDFY3-AS2 contributes to the EMT and metastasis in breast cancer(2016)2 cited